Hdl Handle:
http://hdl.handle.net/10147/107624
Title:
National narcolepsy survey
Authors:
Doherty, L.; Crowe, C.; Sweeney, B.
Affiliation:
Bon Secours Hospital, College Road, Cork. lsdoherty1@hotmail.com
Citation:
National narcolepsy survey. 2010, 103 (4):110, 112-3 Ir Med J
Journal:
Irish medical journal
Issue Date:
Apr-2010
URI:
http://hdl.handle.net/10147/107624
PubMed ID:
20486314
Abstract:
Narcolepsy is characterised by excessive daytime sleepiness and cataplexy and has a prevalence of 25 per 100,000. We suspect this is higher than presently seen in the Republic of Ireland. We aimed to calculate the Irish prevalence of Narcolepsy and to examine current management practices. We conducted an online survey of respiratory physicians, neurologists, paediatric neurologists, and psychiatrists with an interest in sleep disorders (73% response rate). Of this group, a total of 16 physicians managed 180 patients prior to January 2009. A clinical diagnosis alone was reached in 67 (41%) patients, the remainder by polysomnography or multiple sleep latency testing. No patients were diagnosed by cerebro-spinal fluid analysis of hypocretin levels. While 70 (42%) patients received modafanil, only 7 (4%) were treated with sodium oxybate. Even allowing for missing data it is apparent that Narcolepsy is hugely under-diagnosed in Ireland, however, current practises adhere with new international guidelines.
Item Type:
Article
Language:
en
Keywords:
SLEEP DISORDER
MeSH:
Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Health Surveys; Humans; Intracellular Signaling Peptides and Proteins; Ireland; Narcolepsy; Neuropeptides; Polysomnography; Prevalence; Sodium Oxybate
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorDoherty, L.en
dc.contributor.authorCrowe, C.en
dc.contributor.authorSweeney, B.en
dc.date.accessioned2010-07-14T15:04:11Z-
dc.date.available2010-07-14T15:04:11Z-
dc.date.issued2010-04-
dc.identifier.citationNational narcolepsy survey. 2010, 103 (4):110, 112-3 Ir Med Jen
dc.identifier.issn0332-3102-
dc.identifier.pmid20486314-
dc.identifier.urihttp://hdl.handle.net/10147/107624-
dc.description.abstractNarcolepsy is characterised by excessive daytime sleepiness and cataplexy and has a prevalence of 25 per 100,000. We suspect this is higher than presently seen in the Republic of Ireland. We aimed to calculate the Irish prevalence of Narcolepsy and to examine current management practices. We conducted an online survey of respiratory physicians, neurologists, paediatric neurologists, and psychiatrists with an interest in sleep disorders (73% response rate). Of this group, a total of 16 physicians managed 180 patients prior to January 2009. A clinical diagnosis alone was reached in 67 (41%) patients, the remainder by polysomnography or multiple sleep latency testing. No patients were diagnosed by cerebro-spinal fluid analysis of hypocretin levels. While 70 (42%) patients received modafanil, only 7 (4%) were treated with sodium oxybate. Even allowing for missing data it is apparent that Narcolepsy is hugely under-diagnosed in Ireland, however, current practises adhere with new international guidelines.-
dc.language.isoenen
dc.subjectSLEEP DISORDERen
dc.subject.meshBenzhydryl Compounds-
dc.subject.meshCataplexy-
dc.subject.meshCentral Nervous System Stimulants-
dc.subject.meshHealth Surveys-
dc.subject.meshHumans-
dc.subject.meshIntracellular Signaling Peptides and Proteins-
dc.subject.meshIreland-
dc.subject.meshNarcolepsy-
dc.subject.meshNeuropeptides-
dc.subject.meshPolysomnography-
dc.subject.meshPrevalence-
dc.subject.meshSodium Oxybate-
dc.titleNational narcolepsy surveyen
dc.typeArticleen
dc.contributor.departmentBon Secours Hospital, College Road, Cork. lsdoherty1@hotmail.comen
dc.identifier.journalIrish medical journalen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.